CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-29 | Mock James M Chief Financial Officer | Sale 10b5-1 | −183 | $144.50 | $26K | 5,871 |
| 2024-05-29 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −183 | $144.50 | $26K | 10,768 |
| 2024-05-29 | Hoge Stephen President | Sale 10b5-1 | −341 | $144.50 | $49K | 1,471,777 |
| 2024-05-28 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +328 | 6,054 | ||
| 2024-05-28 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −328 | 3,617 | ||
| 2024-05-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +328 | 10,951 | ||
| 2024-05-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −328 | 3,617 | ||
| 2024-05-28 | Hoge Stephen President | Exercise or conversion 10b5-1 | +610 | 1,472,118 | ||
| 2024-05-28 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −610 | 6,716 | ||
| 2024-05-28 | Mock James M Chief Financial Officer | Sale 10b5-1 | −648 | $162.47 | $105K | 5,726 |
| 2024-05-28 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −1,296 | $162.47 | $211K | 10,623 |
| 2024-05-24 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,326 | 6,374 | ||
| 2024-05-24 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,326 | 3,978 | ||
| 2024-05-24 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +2,652 | 11,919 | ||
| 2024-05-24 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,652 | 7,957 | ||
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $142.95 | $14K | 1,996,831 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $144.40 | $29K | 1,996,631 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $145.03 | $15K | 1,996,531 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $147.06 | $44K | 1,996,231 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −600 | $148.21 | $89K | 1,995,631 |
Page 29 of 38 · 743 trades